Effects of a Single, High Oral Dose of 25-Hydroxycholecalciferol on the Mineral Metabolism Markers in Hemodialysis Patients

Therapeutic Apheresis and Dialysis

Volumn 19, Issue 3, 2015, Pages 212-219

  Teruel, Jose Luis ^b   Fernández Lucas, Milagros ^b   Villafruela, Juan José ^b   Bueno, Blanca ^a   Gomis, Antonio ^b   Paraíso, Vicente ^a   Quereda, Carlos ^b  

^a Refractive Surgeon at Clínica Baviera Madrid   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

25 (OH) Vitamin D; Cholecalciferol; Hemodialysis; Parathyroid hormone

Indexed keywords

25 HYDROXYVITAMIN D; CALCIFEDIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; BIOLOGICAL MARKER; VITAMIN D;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CAUCASIAN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINERAL METABOLISM; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; FOLLOW UP; METABOLISM; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CALCIFEDIOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84930277000     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12279     Document Type: Article

References (37)

1. Pilz S, Tomaschitz A, Friedl C etal. Vitamin D status and mortality in chronic kidney disease. Nephrol Dial Transplant 2011;26:3603-3609.
2. Wolf M, Shah A, Gutiérrez O etal. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72:1004-1013.
3. Wang AY, Lam CW, Sanderson JE etal. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-year prospective cohort study. Am J Clin Nutr 2008;87:1631-1638.
4. Pecovnik-Balon B, Jakopin E, Bevc S, Knehtl M, Gorenjak M. Vitamin D and mortality as a novel nontraditional risk factor for mortality in hemodialysis patients. Ther Apher Dial 2009;13:268-272.
5. Drechsler C, Verduijn M, Pilz S etal.; for The NECOSAD Study Group. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 2011;26:1024-1032.
6. Kaisar MD, Isbel NM, Johnson DW. Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease. Rev Recent. Clin Trials 2008;3:79-88.
7. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 2009;76(Suppl 113):S1-S130.
8. Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW. Prevalence of vitamin D deficiency and safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Prac 2007;105:c132-c138.
9. Tokmak F, Quack I, Schieren G etal. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant 2008;23:4016-4020.
10. Chandra P, Binongo JN, Ziegler TR etal. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 2008;14:10-17.
11. Courbebaisse M, Thervet E, Souberbielle JC etal. Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int 2008;75:646-651.
12. Jean G, Souberbielle JC, Chazot C. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009;24:3799-3805.
13. Matias PJ, Jorge C, Ferreira C etal. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin. J Am Soc Nephrol 2010;5:905-911.
14. Armas LA, Andukuri R, Barger-Lux J, Heaney RP, Lund R. 25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis. Clin J Am Soc Nephrol 2012;7:1428-1434.
15. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S-1086.
16. Jean G, Charra B, Chazot C. Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr 2008;18:395-399.
17. Matias PJ, Ferreira C, Jorge C etal. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009;24:611-618.
18. Drechsler C, Pilz S, Obermayer-Pietsch B etal. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 2010;31:2253-2261.
19. Nigwekar SU, Bhan I, Thadhani R. Nutritional vitamin D in dialysis patients: what to d-iscern? Nephrol Dial Transplant 2011;26:764-766.
20. Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 2007;11:315-321.
21. Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011;6:50-62.
22. Jean G, Terrat JC, Vanel T etal. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant 2008;23:3670-3676.
23. Fournier A, Fardellone P, Achard JM etal. Importance of vitamin D repletion in uraemia. Nephrol Dial Transplant 1999;14:819-823.
24. Melamed ML, Thadhani RI. Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol 2012;7:358-365.
25. Dusso AS. Vitamin D hormonal system: what we know and what we are waiting to find out. Nefrología Sup Ext 2011;2:37-43.
26. Wasse H, Huang R, Long Q, Singapuri S, Raggi P, Tangpricha V. Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis. Am J Clin Nutr 2012;95:522-528.
27. Delanaye P, Weekers L, Warling X etal. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant 2013;28:1779-1786.
28. Jakopin E, Pecovnik Balon B, Ekart R, Gorenjak M. High-dose cholecalciferol supplementation for vitamin D deficiency in haemodialysis patients. J Int Med Res 2011;39:1099-1106.
29. Marckmann P, Agerskov H, Thineshkumar S etal. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant 2012;27:3523-3531.
30. Lambert PW, Stern PH, Avioli RC etal. Evidence for extrarenal production of 1 alpha, 25-dihydroxyvitamin D in man. J Clin Invest 1982;69:722-725.
31. Dusso AS, Finch J, Brown A etal. Extrarenal production of calcitriol in normal and uremic humans. J Clin Endocrinol Metab 1991;72:157-164.
32. Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1 alpha, 25-dihydroxyvitamin D(3). Semin Dial 2007;20:316-324.
33. Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol 2010;21:353-361.
34. Jean G, Terrat JC, Vanel T etal. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1, 25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 2008;110:c58-65.
35. Amrein K, Sourij H, Wagner G etal. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit Care 2011;15:R104.
36. Dusso A, Lopez-Hilker S, Rapp N, Slatopolsky E. Extra-renal production of calcitriol in chronic renal failure. Kidney Int 1988;34:368-375.
37. Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 2006;136:1117-1122.